A Higher CD105-Assessed Microvessel Density and Worse Prognosis in Elderly Patients With Laryngeal Carcinoma
Author(s) -
Gino Marioni,
Alberto Staffieri,
Enzo Manzato,
Giovanni Ralli,
Marco Lionello,
Luciano Giacomelli,
Vlatko Prosenikliev,
Rosario MarcheseRagona,
Alessandra Busnardo,
Francesco Bolzetta,
Stella Blandamura
Publication year - 2011
Publication title -
archives of otolaryngology - head and neck surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-361X
pISSN - 0886-4470
DOI - 10.1001/archoto.2010.244
Subject(s) - endoglin , medicine , stage (stratigraphy) , retrospective cohort study , tertiary referral hospital , disease , carcinoma , gastroenterology , immunohistochemistry , oncology , pathology , cd34 , paleontology , genetics , stem cell , biology
To ascertain the prognostic role of endoglin (CD105)-assessed microvessel density (MVD) in patients older than 65 years with laryngeal squamous cell carcinoma (LSCC), and whether this MVD differed in the elderly patients from younger adult controls.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom